DOJ joins Omnicare lawsuit over alleged Abbott Depakote kickbacks
By
Elizabeth Newman
Dec 31, 2014
The Justice Department has filed a False Claims Act complaint against Omnicare Inc., alleging the pharmaceutical giant received millions in kickbacks from Abbott Laboratories over a 10-year period.
$1.3 million settlement marks second recent deal over SNF supervision of therapy providers
By
Tim Mullaney
Sep 16, 2014
A Maryland nursing home company has agreed to a $1.3 million settlement over charges that it did not prevent overbilling by its contracted therapy provider, federal authorities announced Monday. This is...
Latest therapy-billing showdown could be ominous sign for long-term care providers
By
James M. Berklan
Sep 10, 2014
Don’t let anyone tell you that long-term care operators don’t know how to read between the lines. They might not have known to fear a McKnight’s Monday news item before it broke, but...
DOJ forces observation stay showdown
By
James M. Berklan
Sep 01, 2014
Hospitals have been cast in a harsh light by long-term care advocates recently for allegedly over-using “observation stay” status. The practice can ultimately deny some patients subsequent...
Largest US hospital chain to pay $98 million in observation stay case
By
Tim Mullaney
Aug 06, 2014
The nation’s largest hospital organization has agreed to a $98 million settlement to resolve charges that it overbilled by admitting individuals as inpatients rather than keeping them under observation,...
Provider networks: Too big to succeed?
By
Tim Mullaney
Jan 28, 2014
At this point, you’re well aware that the Affordable Care Act is putting pressure on post-acute providers to partner with hospitals and physician groups. A recent whistleblower case in California...
Government, Abbott Laboratories reach $5.5M settlement over stents
Jan 07, 2014
The Department of Justice and Abbott Laboratories agreed to a $5.48 million settlement on Dec. 27 related to allegations that physicians received kickbacks for pushing stents.
Johnson & Johnson to pay $2 billion in settlement over antipsychotic drugs in nursing homes
By
Tim Mullaney
Nov 05, 2013
Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes, the U.S....
Latest Medicare fraud allegations just an appetizer
By
John O'Connor
May 10, 2013
As we’ve been predicting here for some time, allegations of mismanaged therapy care are starting to land nursing homes in some seriously hot water.
False Claims lawsuit, government report raise questions about expensive types of hospice care
By
McKnight's Staff
May 08, 2013
A government lawsuit and a memorandum from the Department of Health and Human Services Office of Inspector General raise questions about the two most expensive types of hospice care.